Bio-Rad Laboratories, Inc. Profile Avatar - Palmy Investing

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. Th…
Medical - Devices
US, Hercules [HQ]
BIO/Financial Reporting

Income Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
1,784.00 1,927.00 2,073.00 2,069.00 2,132.00 2,175.00 2,019.00 2,068.00 2,160.00 2,290.00 2,311.00 2,545.00 2,922.00 2,802.00 2,671.00
EPS
5.28 6.70 6.39 5.85 2.72 3.08 3.74 0.88 4.12 12.10 58.93 127.86 142.61 -121.79 -21.82
Profit
999.00 1,091.00 1,177.00 1,161.00 1,178.00 1,178.00 1,121.00 1,138.00 1,187.00 1,224.00 1,256.00 1,437.00 1,640.00 1,567.00 1,431.00
Pre Tax
185.00 220.00 235.00 231.00 112.00 131.00 145.00 41.00 97.00 507.00 2,261.00 4,907.00 5,438.00 -4,704.00 -850.00
ETR
19.73 15.14 24.49 26.89 30.76 32.47 22.46 32.33 -17.32 28.85 22.22 22.44 21.92 22.89 25.03
Net
144.00 185.00 178.00 169.00 77.00 88.00 113.00 28.00 114.00 360.00 1,758.00 3,814.00 4,254.00 -3,627.00 -637.00
EBITDA
336.00 392.00 416.00 416.00 329.00 312.00 309.00 273.00 289.00 366.00 389.00 573.00 650.00 664.00 576.00
Operating Income
230.00 284.00 295.00 264.00 169.00 149.00 166.00 53.00 116.00 -108.00 229.00 410.00 489.00 482.00 383.00
Interest Income
- - - - - - 11.00 13.00 13.00 10.00 14.00 19.00 26.00 30.00 18.00 18.00 58.00 100.00
Loss
-1,549.00 -1,643.00 -1,778.00 -1,805.00 -1,963.00 -2,025.00 -1,852.00 -1,952.00 -2,031.00 -2,098.00 -2,081.00 -2,134.00 -2,433.00 -2,319.00 -2,287.00
Cost of Revenue
-784.00 -835.00 -895.00 -908.00 -954.00 -996.00 -897.00 -930.00 -972.00 -1,065.00 -1,054.00 -1,107.00 -1,281.00 -1,234.00 -1,239.00
Operating Expenses
-765.00 -807.00 -882.00 -896.00 -1,009.00 -1,028.00 -954.00 -1,022.00 -1,059.00 -1,032.00 -1,027.00 -1,026.00 -1,151.00 -1,084.00 -1,047.00
Depreciation and Amortization
-101.00 -108.00 -120.00 -130.00 -147.00 -149.00 -131.00 -142.00 -148.00 -138.00 -134.00 -138.00 -133.00 -137.00 -192.00
Interest Expenses
-47.00 -63.00 -53.00 -49.00 -61.00 -22.00 -21.00 -21.00 -21.00 -23.00 -23.00 -21.00 -1.00 -38.00 -49.00
Other Expenses
-1.00 - - -6.00 -16.00 -4.00 -3.00 - - -51.00 -8.00 -339.00 -2,031.00 -4,496.00 -4,948.00 -5,186.00 -1,233.00
WA Shares Outstanding
27.00 27.00 28.00 28.00 28.00 28.00 29.00 29.00 29.00 29.00 29.00 29.00 29.00 29.00 29.00
End of BIO's Analysis
CIK: 12208 CUSIP: 090572207 ISIN: US0905722072 LEI: - UEI: -
Secondary Listings